Drug archive
Factor VIIa (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antihemorrhagic
Description
Factor VIIa is a man-made protein produced to replicate the naturally occurring activated factor VII (factor VIIa) in the body. Factor VIIa is used to stop bleeding of injuries for patients with hemophilia by helping the blood to clot. This man-made protein, factor VIIa, is used in people who have Hemophilia A or Hemophilia B, who have also formed antibodies against other clotting proteins that help bleeding to stop. Patients using factor VIIa are usually male.
Factor VIIa is to be administered only by or under the supervision of your doctor or other health care professional. It is available in the following dosage form(s):
- Injection (U.S.)
Brand Names
Some commonly used brand names are:
In the U.S. -
- NovoSeven
Other commonly used names are coagulation factor VIIa (recombinant) , eptacog alfa , factor 7 , proconvertin , recombinant activated factor VIIa , recombinant coagulation factor VIIa , recombinant factor VIIa , and rFVIIa.
† Not commercially available in Canada.